Modern Bioscience's proprietary DDS technology, polymeric transporter technology, uses bio-friendly polymers.
It is a groundbreaking technology that can improve the duration of the blood concentration of drugs and reduce side effects.
Hyundai Bioscience applies polymer carrier technology to chemical anticancer drugs to reduce toxicity,
the biggest disadvantage of chemical anticancer drugs, and causes side effects.
On the other hand, we developed a polytaxel that can show better anticancer efficacy
by enabling changes in drug administration intervals.
The technology has been introduced in the international journal International Journal of Nanomedicine.